COMMUNIQUÉS West-GlobeNewswire

Agios Reports Fourth Quarter and Full Year 2017 Financial Results

14/02/2018 - 13:01

– All 2017 Key Milestones Achieved, Including First U.S. Product Approval from Agios’ Discovery Platform and NDA Submission for Second Product Candidate, Ivosidenib, for IDH1m R/R AML – – 2018 Priorities Focus on [...]

Midatech Pharma Plc: Trading update

14/02/2018 - 13:00

14 February 2018 Midatech Pharma PLC ("Midatech", "Company" or "Group") Trading update Midatech (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused on developing and commercialising [...]

AxoGen, Inc. to Report Fourth Quarter and Full-Year 2017 Financial Results and Host Conference Call on February 28, 2018

14/02/2018 - 13:00

ALACHUA, Fla., Feb. 14, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN ), a global leader in developing and marketing innovative surgical solutions for the repair of peripheral nerve injuries, today announced that [...]

G1 Therapeutics to Report Fourth Quarter and Full-Year 2017 Financial Results on February 21, 2018

14/02/2018 - 13:00

RESEARCH TRIANGLE PARK, N.C., Feb. 14, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a clinical-stage oncology company, today announced that fourth quarter and full-year 2017 financial results will be [...]

Microbix Reports Record First Quarter Sales

14/02/2018 - 13:00

TORONTO, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX ) (Microbix®), an innovator of biological products and technologies, reports financial results for its first quarter of fiscal 2018, the [...]

Hydropothecary signs letter of intent to supply Québec market

14/02/2018 - 12:45

Hydropothecary signs LOI with Société des alcools du Québec for supply of cannabis. Hydropothecary will supply 20,000 kg of cannabis for the first year of the adult-use recreational cannabis. The LOI covers the full [...]

Hydropothecary signe une lettre d’intention pour approvisionner le marché québécois

14/02/2018 - 12:45

La Société signe une lettre d’intention avec la Société des alcools du Québec concernant l’approvisionnement en cannabis. Hydropothecary fournira 20 000 kg de produits de cannabis pour la prochaine année. La lettre d’ [...]

Merus Announces $55.8 Million Private Placement Offering of Common Stock

14/02/2018 - 12:00

UTRECHT, The Netherlands, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS ), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced that [...]

Herantis Pharma opening recruitment in Parkinson's disease study in Helsinki and Lund based on favorable first CDNF safety assessment

14/02/2018 - 08:01

Herantis Pharma opening recruitment in Parkinson's disease study in Helsinki and Lund based on favorable first CDNF safety assessment Herantis Pharma Plc Company release 14 February 2018 at 9:00 am Herantis Pharma Plc's [...]

Enzymatica AB: Strong growth and international breakthrough in 2017

14/02/2018 - 08:01

Interim report for Enzymatica AB (publ) JANUARY- DECEMBER 2017 Strong growth and international breakthrough in 2017 Q4 Net sales reached SEK 19.1 (11.3) million. Net profit after tax came in at SEK -5.6 (-17.6) million [...]

DBV Technologies Provides Update on Regulatory Progress for Viaskin Peanut

14/02/2018 - 07:31

Press Release Montrouge, France, February 14, 2018 DBV Technologies Provides Update on Regulatory Progress for Viaskin Peanut DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today [...]

DBV Technologies annonce les avancées réglementaires de Viaskin Peanut

14/02/2018 - 07:31

Communiqué de presse Montrouge, France, le 14 février 2018 (7h30 CET) DBV Technologies annonce les avancées réglementaires de Viaskin Peanut DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: [...]

Novartis forms alliance to develop medicines for treating infectious diarrheal disease

14/02/2018 - 07:16

Novartis receives funding from Bill & Melinda Gates Foundation for further development of Novartis drug candidate KDU731 for the treatment of cryptosporidiosis Cryptosporidiosis is the second leading cause of [...]

Sensorion Presents New SENS-401 Data at ARO 2018 MidWinter Meeting

14/02/2018 - 07:00

MONTPELLIER, France, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468:ALSEN), a biotech company specializing in the treatment of inner ear diseases, today announces new data presented in multiple poster [...]

Arbutus Announces Departure of Chief Financial Officer; Appoints Interim CFO

14/02/2018 - 03:36

VANCOUVER, British Columbia and WARMINSTER, Pa., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS ), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, announced [...]

Cannabis Wheaton Income Corp. Announces Prior Engagement of Investor Relations Firms

14/02/2018 - 02:00

VANCOUVER, British Columbia, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (TSX.V:CBW) (the " Company ") announces that it previously retained each of IRTH Communications, LLC (" IRTH "), Skanderbeg [...]

National Research Corporation Announces Fourth Quarter and Year-End 2017 Results

14/02/2018 - 00:57

LINCOLN, Neb., Feb. 13, 2018 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ: NRCIA ) (NASDAQ: NRCIB ) today announced results for the fourth quarter and year end 2017. Fourth Quarter Net New Sales $6.2 [...]

Vigil Reports Record Sales Bookings in Third Quarter

13/02/2018 - 23:23

VICTORIA, British Columbia, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Vigil Health Solutions Inc. (TSX-VEN: VGL) (“Vigil”) announces the results of operations for the quarter ending December 31, 2017. Business Highlights Sales [...]

Oncobiologics Receives Positive Nasdaq Listing Determination

13/02/2018 - 22:36

CRANBURY, N.J., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ: ONS ) (NASDAQ: ONSIW ) (NASDAQ: ONSIZ ) announced today that on February 13, 2018, the Company received formal notice that the Nasdaq [...]